MPN Research
Funds research focused on myeloproliferative neoplasms.
A cancer research funding organization. The Cancer Research & Treatment Fund (CR&T) supports research focused on myeloproliferative neoplasms (MPNs), as well as other blood cancers and solid tumors. Its grants address cancer causes, prevention, treatment, and cures, and include clinical trials. CR&T may provide seed funding for promising research initiatives. Since its founding in 1968, the organization has awarded more than $17 million in research grants. Its work is guided by a Medical Advisory Board of physician-scientists, and its Young Professionals program engages emerging leaders. The fund also supports the Richard T. Silver, MD Myeloproliferative Neoplasm Center. Based in New York City, CR&T directs more than 80 cents of every dollar to research and education.
Disclosure: Profile information has been compiled from publicly available sources and has not yet been verified by the business.
Representative photos. Illustrative images for this category, not photos of Cancer Research & Treatment and not provided by the business.
Funds research focused on myeloproliferative neoplasms.
Supports blood and solid tumor cancer research, including trials.
Provides early funding for promising research initiatives.
No reviews yet — be the first to review Cancer Research & Treatment.
Sign in to write a review
No password needed. We only use your email to confirm the review is genuine.
Tell our moderators what is wrong with the review by this reviewer and we will take a look.